Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy

Sponsor
Jens Borglum Neimann (Other)
Overall Status
Completed
CT.gov ID
NCT01837394
Collaborator
(none)
60
1
2
13
4.6

Study Details

Study Description

Brief Summary

In this study, we wish to investigate the effect of ultrasound (US) -guided block of the saphenous nerve (SN) and the posterior branch of the obturator nerve (ONP) on postoperative pain and the use of opioids (morphine-like pain medicine) in the first 24 hours following ambulatory knee arthroscopy.

We wish to investigate the analgesic effect of these two blocks compared to placebo (injection of local anesthetic with known pain blocking properties compared with injection of a saline solution), when used as a supplement to conventional oral analgesics.

We hypothesize that patients receiving the active treatment may experience less pain during the first 24 hours after their operation than patients receiving the placebo treatment, and possibly require less opioid analgesics, experience less opioid related side effects and have a higher function level in this period than patients receiving the placebo treatment.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Ultrasound-guided Block of the Saphenous Nerve and Obturator Nerve, Posterior Branch, for Postoperative Pain Management After Ambulatory Knee Arthroscopy
Study Start Date :
Aug 1, 2012
Actual Primary Completion Date :
Jun 1, 2013
Actual Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Block arm

Ultrasound guided block of the SN and ONP with 7.5 ml of Ropivacaine 7.5 mg/ml injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

Procedure: Block of the SN and ONP
7.5 ml of Ropivacaine 7.5 mg/ml injected at each site
Other Names:
  • Naropin
  • Drug: Paracetamol
    Other Names:
  • Acetaminophen
  • Drug: Morphine
    5 mg as needed

    Drug: Ondansetron
    4 mg i.v. as needed in the PACU
    Other Names:
  • Zofran
  • Drug: Metoclopramide
    10 mg tablet as needed in the postoperative period after discharge from the PACU
    Other Names:
  • Emperal
  • Primperan
  • Placebo Comparator: Placebo arm

    Ultrasound guided placebo block of the SN and ONP with 7.5 ml of isotonic saline solution injected at each site, respectively, immediately prior to induction of general anesthesia. Standard postoperative analgesia with paracetamol 1 g every 6 hours and Morphine 5 mg as needed. Ondansetron or Metoclopramide as needed for nausea.

    Procedure: Placebo block
    7.5 ml of isotonic saline solution 154 mmol/l injected at each site
    Other Names:
  • NaCl
  • Drug: Paracetamol
    Other Names:
  • Acetaminophen
  • Drug: Morphine
    5 mg as needed

    Drug: Ondansetron
    4 mg i.v. as needed in the PACU
    Other Names:
  • Zofran
  • Drug: Metoclopramide
    10 mg tablet as needed in the postoperative period after discharge from the PACU
    Other Names:
  • Emperal
  • Primperan
  • Outcome Measures

    Primary Outcome Measures

    1. Pain on knee flexion [24 hours postoperatively]

      VRS (Verbal Rating Scale) score 0-10 on active flexion of the knee to 45 degrees, measured at 0, ½, 1, 2, 3, 4, 6, 8, 12 and 24 hours postoperatively and analyzed by area under curve (AUC) analysis.

    Secondary Outcome Measures

    1. Pain at rest [24 hours postoperatively]

      VRS (verbal rating score) 0-10 at rest, measured at 0, ½, 1, 2, 3, 4, 6, 8, 12 and 24 hours postoperatively and analyzed by area under curve (AUC) analysis.

    2. Time to opioid intake [24 hours postoperatively]

      First time the patient needs to take supplementary opioids in the postoperative period

    3. Total opioid intake [24 hours]

      Total dose of opioids taken in the first 24 hours postoperatively

    4. Nausea [24 hours postoperatively]

      VRS score 0-10, measured at 0, ½, 1, 2, 3, 4, 6, 8, 12 and 24 hours postoperatively and analyzed by area under curve (AUC) analysis.

    5. Vomiting [24 hours]

      Number of times the patient has vomited in the first 24 hours postoperatively.

    6. Use of antiemetics [24 hours]

      Total dose of antiemetics taken during the first 24 hours postoperatively

    7. PACU length of stay [24 hours]

      Total length of stay in the post anesthetic care unit (PACU) after the operation.

    8. Function level: Barthel Index/100 [24 hours]

      Modified Barthel Index/100 score 24 hours after the operation.

    9. Function level: Short form (SF) -8 [24 hours]

      Short form (SF) -8 questionnaire 24 hours postoperatively

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Planned ambulatory knee arthroscopy, except cruciate ligament surgery

    • American Society of Anesthesiologists (ASA) class 1-3

    Exclusion Criteria:
    • Cannot cooperate

    • Do not speak or understand Danish

    • Daily use of opioid analgesics

    • Allergy towards any of the drugs used in the investigation

    • Medicine abuse (at the investigators discretion)

    • Alcohol abuse, as defined by the National Board of Health

    • General anesthesia contraindicated, or the patient wants spinal anesthesia

    • Visualization of necessary structures by ultrasound not possible, or block not possible for other technical reasons

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anesthesiology, Bispebjerg Hospital Copenhagen Denmark 2400

    Sponsors and Collaborators

    • Jens Borglum Neimann

    Investigators

    • Principal Investigator: Bo Westergaard, MD, Department of Anesthesiology, Bispebjerg Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jens Borglum Neimann, MD, PhD, MBA, Bispebjerg Hospital
    ClinicalTrials.gov Identifier:
    NCT01837394
    Other Study ID Numbers:
    • H-2-2011-029
    First Posted:
    Apr 23, 2013
    Last Update Posted:
    Nov 6, 2013
    Last Verified:
    Nov 1, 2013
    Keywords provided by Jens Borglum Neimann, MD, PhD, MBA, Bispebjerg Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 6, 2013